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756a Wednesday, February 24, 2010its>6000 anti-human polyclonal, affinity-purified antibodies of which 49 were
identified by MS and 79 were novel. HPA antibodies were available for 82 the
142 proteins but only 43 reacted positively with the ICDs based on immunohis-
tochemistry. We supplement these approaches with 14 proteins identified using
conventional 2-DE. Combining all techniques. Only 14 proteins were common
to the MS data, HPA antibodies and the literature. We can categorize all 273
identified ICD proteins according to their known functions and demonstrate
their functional interactions in a single inter-active relationship according to
their functions: (i) adhesion, anchoring and binding (88); (ii) enzymes (46);
(iii) proteins that maintain the structure and function of the ICDs (35); (iv) myo-
fibrillar (34); (v) channels (32); (vi) ligands and their receptors (18); (vii) cyto-
plasm proteins (6); and (viii) mechanoreceptors (4). We will now extend these
analyses to ICD proteins that change as a result of human heart failure.
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Phosphorylation sites in Cardiac MyBP-C have been predicted at Ser273,282
and 302 but studies in intact tissue have identified 5 phosphorylted sites and
suggested up to 4.6molsPi/mol MyBP-C is present in human heart.
We analysed MyBP-C phosphospecies in human heart myofibrils by phosphate
affinity SDS-PAGE using a non-specific antibody raised against the MyBP-C
peptide 2-14. We observed six bands corresponding to 0, 1P, 2P, 3P, 4P, 5P
phospho-species. Control experiments with pure MyBP-C indicated that the
antibody labelled all phosphospecies equally. The assigned phosphorylation
levels were confirmed by staining western blots with PhosTools phosphopro-
tein stain. This separation permits direct quantitative determination of
MyBP-C phosphospecies without need for calibration.
In donor heart myofibrils the highly phosphorylated species predominated: 0,
753%: 1P, 151%: 2P, 2357%: 3P, 4152%: 4P, 2058% (n=4) from which
total phosphorylation of MyBP-C was calculated to be 3.4molsPi/mol. In fail-
ing heart unphosphorylated MyBP-C predominated (0, 4854%: 1P, 454%:
2P, 2755%: 151%: 3P, 1754%: 4P, 452%, n=4) and calculated total phos-
phorylation was 1.5 molsPi/mol. Total phosphorylation in failing heart myofi-
brils was 44% of donor and in myectomy samples from HCM patients it was
29% of donor, compared with 45 and 40% respectively determined in previous
assays.
We conclude that MyBP-C is highly phosphorylated in vivo with significant
phosphorylation of at least 5 sites and that phosphorylation is dynamic, being
greatly reduced in pathological muscle. Initial tests using antibodies specific
to Ser 273, 282 and 302 show distinct patterns on phosphate affinity SDS-
PAGE indicating varying preferences for the highly phosphorylated species
of MyBP-C in normal and pathological muscle.
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N-terminal domains of cardiac myosin binding protein-C (cMyBP-C) can acti-
vate actomyosin interactions in the absence of Ca2þ and bind to actin in a phos-
phorylation dependent manner. We have previously shown that two N-terminal
domains, C1 and the MyBP-C motif (‘‘M’’) domain, bind specifically to actin
and to thin filaments; however, the sequences or residues that mediate actin
binding have not been identified. The goal of this study was to identify residues
in the M-domain that contribute to actin binding and to investigate whether in-
teractions between the M-domain and actin mediate the activating properties of
cMyBP-C. We therefore used alanine-scanning mutagenesis to target candidate
actin binding sites in the M-domain that bear homology to the actin binding
motifs in other known actin binding proteins and to assess the effects of muta-
tions on the ability of recombinant proteins to bind actin and activate actomy-
osin interactions in motility assays. Results demonstrate that mutation of select
positively-charged amino acids in the M-domain that are homologous to bind-
ing motifs in known actin binding proteins reduced binding of cMyBP-C to
actin. The mutations also reduced or eliminated the activating properties of re-
combinant cMyBP-C in in vitro motility assays. However, mutation of other
positively-charged amino acids did not affect actin binding or protein func-
tional properties. These results indicate that specific residues within the M-do-
main confer actin binding and that interactions with actin contribute to the func-
tional effects of recombinant cMyBP-C N-terminal proteins. Supported by NIH
HL080367 to SPH and a NSF Graduate Research Fellowship to JFS.3935-Plat
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Cardiac myosin binding protein-C (cMyBP-C) mutations are a leading cause of
hypertrophic cardiomyopathy. cMyBP-C has 11 domains, C0 through C10, that
bind sarcomeric proteins, including myosin and actin. A 29 kDN-terminal frag-
ment (C0C1f) of cMyBP-C containing the first two domains C0 and C1 and the
first 15 residues of the conserved MyBP-C motif is cleaved from cMyBP-C fol-
lowing ischemic-reperfusion injury (Sadayappan et al., JMCC 44:S44, 2008).
Expressed C0C1f fragments inhibit actin velocities in the motility assay at
a 2:1 molar ratio to myosin, similar to other N-terminal fragments: C0C3,
C0C2, and C1C2. Interestingly, fragments containing only the C0C1 domains
do not alter velocity, suggesting the additional 15 residues in C0C1f are neces-
sary for inhibition. Adding C0C1 to the motility assay can partially reverse the
C0C3-mediated inhibition of velocity, suggesting C0C1 may compete with
C0C3 for actin binding. cMyBP-C fragments may affect motility by creating
a tether between actin and the flowcell surface. To test this, motility experi-
ments were performed under high ionic strength, saturating MgATP, and in
the absence of methylcellulose, conditions in which most actin filaments dif-
fuse away from the surface due to weak interactions with myosin. In the pres-
ence of C0C2, many actin filaments bound and translocated on the surface, con-
firming this fragment’s tethering capacity. Additionally, in the laser trap we
adhered C0C3 fragments to a bead in the absence of myosin and observed
C0C3 transiently binding to a single actin filament with an ~100 ms attached
lifetime. We also saw evidence that C0C3 may partially unfold under load.
These experiments strongly suggest that N-terminal domains of cMyBP-C con-
taining the MyBP-C motif tether actin filaments and provide one mechanism
for modulating actomyosin motion generation, i.e. by imposing an effective
viscous load within the sarcomere.
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Protein Kinase C (PKC) regulates contractility of cardiac muscle cells by phos-
phorylating multiple thin- and thick- filament based proteins, and plays key
roles in development of cardiovascular pathologies. Myocardial sarcomeres
also contain a third myofilament, titin, which we demonstrate here to also be
phosphorylated by PKC. Titin phosphorylation was observed in skinned myo-
cardial tissues following incubation with PKCa and this effect was exacerbated
~5 fold in the mouse and ~2.5 fold in the pig by preincubation with Protein
Phosphatase 1 (PP1). In vitro phosphorylation of recombinant protein repre-
senting titin’s spring elements shows that PKCa targets the PEVK spring
element. Mass spectrometry in combination with site-directed mutagenesis
identified two highly conserved sites in the PEVK region that are phosphory-
lated by PKCa (S11878 and S12022); when these two sites are mutated to
alanine, phosphorylation is effectively abolished. Mechanical experiments
with murine and porcine skinned LV myocardium revealed that PKCa
significantly increases titin-based passive tension in a sarcomere length (SL)-
dependent fashion. Single molecule force-extension curves show that PKCa
decreases the PEVK persistence length (from 1.20 nm to 0.55 nm), without
altering the contour length, and using a serially-linked wormlike chain
(WLC) model we show that this results in an ~20% increase in titin-based pas-
sive force with a SL dependence that is similar to that measured in skinned
myocardium following PKCa phosphorylation. We conclude that PKC phos-
phorylation of titin is a novel and conserved pathway that links myocardial sig-
naling and myocardial stiffness.
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The giant sarcomeric protein, titin is the primary determinant of myocardial
passive stiffness. In failing human hearts however, it has been proposed that re-
duced myofilament passive tension is due to an altered titin isoform expression
profile1, 2. In this study we set out to directly quantify the tensile strength of titin
molecules isolated from healthy and diseased myocardium.
Wednesday, February 24, 2010 757aHeart failure was induced in adult male ferrets by ascending aortic coarctation.
All procedures accorded with The United Kingdom Animals (Scientific Proce-
dures) Act, 1986. Protein extracts from sham and failing hearts were separated
by 2% SDS PAGE. The mean ratio of the major titin isoforms N2BA:N2B in-
creased from 0.3 in control to 0.5 in failing hearts (n=6, p<0.01).
Titin molecules were isolated from left ventricle, aligned and stretched by a re-
ceding liquid meniscus (which applied a tensile force of ~60pN)3 and visual-
ised by atomic force microscopy. Combed titin molecules exhibited a straight-
ened and beaded appearance. The mean molecular diameter of titin decreased
in failing hearts compared to control (0.2650.001nm vs 0.3350.001nm,
p<0.001, n=104-130 molecules, 3 animals per group). This difference was
more pronounced in the shorter molecules (<3.5 mm). The mean distance be-
tween beads was increased in failing hearts (49.351.5nm vs 126.854.5nm,
p<0.001, n=370-429, 3 animals per group). The decreased titin molecular di-
ameter combined with an increased inter-bead distance suggests that titin
from failing hearts is less resistant to tensile forces when compared to control,
and may help to explain the decreased titin-based passive tension observed in
diseased hearts.
Reference List
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Isoform switching of the giant elastic protein titin is a main mechanism for ad-
justing passive myocardial stiffness in perinatal heart development and chronic
heart disease. Previous evidence suggested that thyroid hormone (T3) signaling
converging onto the phosphoinositol-3-kinase (PI3K)/AKT pathway is an im-
portant determinant of the cardiac titin-isoform pattern in developing cardio-
myocytes. We hypothesized that other activators of PI3K/AKT, particularly in-
sulin, may similarly alter the titin-isoform composition, thereby modifying
titin-based stiffness. Embryonic rat cardiomyocytes were cultured in medium
containing 0.5% hormone-reduced serum and were treated with 175 nmol/L in-
sulin for seven days. Analysis of titin-isoform expression by 2% SDS-PAGE
showed a significant increase in the mean proportion of the stiff N2B titin iso-
form (3,000 kDa), from 53% in control cells to 64% in insulin-treated cells, the
remainder being the more compliant N2BA isoform (>3,200 kDa). This insu-
lin-dependent titin-isoform shift was blocked in the presence of PI3K-inhibitor,
LY294002, suggesting that insulin regulates the cardiac titin-isoform pattern by
activating the PI3K/AKT pathway. Whether this mechanism operates in vivo
was studied by testing the effect of insulin deficiency on titin-isoform expres-
sion in streptozotozin-treated (STZ) rats as a model for diabetes mellitus (type
1). Within four months, STZ rats developed cardiac hypertrophy and mild left
ventricular (LV) fibrosis, concomitant with elevated glucose levels. The mean
proportion of N2B-titin was significantly decreased from 86% in control LV to
78% in LV of STZ rats. Wormlike chain modeling of titin elasticity suggested
that such a change reduces titin-based passive stiffness by ~6%. Results of me-
chanical measurements on skinned cardiac fiber bundles confirmed minor pas-
sive stiffness modifications in STZ myocardium. We conclude that insulin sig-
naling regulates titin-isoform composition in cardiac development and could
also contribute to altered diastolic function in diabetic cardiomyopathy.
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Embryonic or induced pluripotent stem cells have great potential to treat mul-
tiple cardiopathologies. Current limitations include a lack of understanding
how contractility of immature cardiomyocytes is affected by microenvironment
mechanical properties and beta-adrenergic stimulation. Inability to apply tradi-
tional force assessment techniques to immature cardiomyocytes led us to utilize
6 micrometer spaced arrays of elastomer-based microfabricated post force sen-
sors. Posts act as cantilever springs with tunable constants (kp (nN/microme-
ter)), deflecting linearly in response to cultured cell’s acto-myosin contraction
transmitted through focal adhesions formed at their tips. We combined this
method with an IonOptix system for real-time post displacement and intracel-
lular Caþþ flux monitoring. We found for neonatal rat cardiomyocytes (NRCs)
exposed to nanomolar concentrations of the b-adrenergic stimulant isoprotere-
nol for ~2 minutes Caþþ flux decreased with little effect on flux rates. Maxi-
mum contractile force increased by as much as 90 % with 100 nM isoproterenolalong with a significant increase in relaxation rate (kr). NRCs cultured on post
arrays with an effective modulus (calculated based upon the kp) greater than
normal cardiac extracellular matrix (~29.3 kPa vs. 10-20 kPa, respectively)
generated the largest force per post (56.059.8*! nN) and the fastest kr
(0.4450.08yd nN/ms) compared to post with Ep~10.6 kPa (16.152.7!%
nN, and 0.1650.030# nN/ms) and Ep~23.0 kPa (30.654.5*%y nN,
0.1450.023#d nN/ms). Interestingly, kr for lower Ep values remained un-
changed (#pvalue=0.349) while force increased with stiffness. Immunofluores-
cence staining revealed that myofibril actin and z-disc associated vinculin were
more organized into parallel, longer fibers on stiffer post arrays. Increased con-
tractility on stiffer posts also correlated with increased isoproterenol effects.
The results indicate stiffness of the microenvironment at NRC’s focal adhesive-
ness play a critical role in determining contractility and b-adrenergic respon-
siveness. (*,!,%,ypvalue<0.05, 5SEM) HL061683(MR); NSF CAREER
and HL097284(NS)Platform BG: Nano-Materials
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Biological molecules perform sophisticated functions in living systems with
complexity often far exceeding most of man-made devices and objects. Direct
integration of biological components with electronic circuits could drastically
increase their efficiency, complexity, and capabilities and result in novel sens-
ing and signaling architectures. Yet, one of the obstacles for this vision of a
bionanoelectronic circuit is the absence of a versatile interface that facilitates
communication between biomolecules and electronic materials. We have
been building platforms that integrates membrane proteins with one-dimen-
sional inorganic materials such as carbon nanotubes and silicon nanowires.
In our devices, a nanotube of nanowire is covered by a lipid bilayer that serves
both as a universal membrane protein matrix and an insulating shield. I will dis-
cuss the fabrication and properties of these ‘‘shielded’’ nanowires and of their
use in bionanoelectronic devices that incorporate working membrane proteins
in an electronic circuit.
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There is considerable interest in the use of carbon nanotubes (CNTs) as ‘nano-
syringes’that span membranes. These nanosyringes form biomimetic pores ca-
pable of drug delivery or of the selective transport of ions and water in biosen-
sor devices. To date, a number of different types of simulation system have
been used to explore the transport properties of CNT nanopores. These range
from isolated CNTs in water, through to CNTs in a bilayer-mimicking ‘slab’.
However, it has been shown that what lies outside a nanopore may have an im-
portant effect on its transport properties, arguing for more realistic membrane
models to be used. Up to now, few studies have addressed the transport prop-
erties of CNT nanopores embedded in a phospholipid bilayer. This more com-
plex system may capture important effects of the membrane environment on
the functional behaviour of the nanopore. Here we use molecular dynamics
to simulate CNT nanopores that are embedded in a lipid bilayer. We explore
how the size of the nanopore influences both its interactions with the lipid bi-
layer and the transport properties through the pore.
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Metal nanostructures are attracting increasing attention in bio-sciences owing
to their versatility and the peculiarities of their optical properties1,2. Their ex-
ploitation, however, often demands stable and biocompatible multifunctional
surface coating.
We shall present a single-step method to coat and functionalize gold nanopar-
ticles (NPs) with two distinct reactive groups by a properly designed peptide.
NPs were prepared by reducing tetrachloro auric acid in water. The peptide
we employed bonds to the NP by the N-Cysteine aminoacid and terminates
with a C-terminal Lysine. In this way we can produce stable nanospheres
